The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
People with Down syndrome (DS), caused by trisomy of chromosome 21 have a greatly increased risk of developing Alzheimer's disease (AD). This is in part because of triplication of a chromosome 21 gene, APP. This gene encodes amyloid precursor protein, which is cleaved to form amyloid-β that acc...
Enregistré dans:
Auteurs principaux: | Yixing Wu, Heather T Whittaker, Suzanna Noy, Karen Cleverley, Veronique Brault, Yann Herault, Elizabeth M C Fisher, Frances K Wiseman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef70aabd7c9645f4a1ceae65bf660fef |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
par: Justin L. Tosh, et autres
Publié: (2021) -
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
par: Justin L. Tosh, et autres
Publié: (2021) -
Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
par: Eric A Tanifum, et autres
Publié: (2012) -
<i>Dyrk1a</i> from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
par: Helin Atas-Ozcan, et autres
Publié: (2021) -
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
par: Nikisha Carty, et autres
Publié: (2013)